<unk> (human) is an antihemophilic agent that is FDA approved for the treatment of classical hemophilia (hemophilia A) in which there is a demonstrated deficiency of activity of the plasma clotting<unk> ,<unk>  VIII. Koāte-DVI provides a means of temporarily replacing the missing clotting<unk>  in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.   Common adverse reactions include angina, cold extremities, and hypotension.
Antihemophilic Factor 
Antihemophilic factor
Antihemophilic factor 
Lupus anticoagulant
Antithrombin III
Factor ix complex
Immunoglobulin E
Thrombus precursor protein 